- Home
- FMX vs EW Comparison
FMX vs EW Comparison
Compare FMX & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMX
- EW
- Stock Information
- Founded
- FMX 1890
- EW 1958
- Country
- FMX Mexico
- EW United States
- Employees
- FMX N/A
- EW N/A
- Industry
- FMX Beverages (Production/Distribution)
- EW Industrial Specialties
- Sector
- FMX Consumer Staples
- EW Health Care
- Exchange
- FMX Nasdaq
- EW Nasdaq
- Market Cap
- FMX 35.0B
- EW 40.7B
- IPO Year
- FMX 1998
- EW 2000
- Fundamental
- Price
- FMX $101.95
- EW $73.68
- Analyst Decision
- FMX Buy
- EW Buy
- Analyst Count
- FMX 5
- EW 20
- Target Price
- FMX $103.95
- EW $79.45
- AVG Volume (30 Days)
- FMX 684.9K
- EW 4.3M
- Earning Date
- FMX 04-28-2025
- EW 04-23-2025
- Dividend Yield
- FMX 0.23%
- EW N/A
- EPS Growth
- FMX 44.10
- EW 201.77
- EPS
- FMX 0.40
- EW 7.02
- Revenue
- FMX $39,193,428,202.00
- EW $5,522,300,000.00
- Revenue This Year
- FMX $12.03
- EW $10.07
- Revenue Next Year
- FMX $7.86
- EW $9.65
- P/E Ratio
- FMX $23.24
- EW $10.54
- Revenue Growth
- FMX 11.32
- EW N/A
- 52 Week Low
- FMX $81.08
- EW $58.93
- 52 Week High
- FMX $123.09
- EW $95.25
- Technical
- Relative Strength Index (RSI)
- FMX 50.33
- EW 52.18
- Support Level
- FMX $101.65
- EW $74.25
- Resistance Level
- FMX $104.97
- EW $76.13
- Average True Range (ATR)
- FMX 2.61
- EW 1.75
- MACD
- FMX -0.58
- EW -0.02
- Stochastic Oscillator
- FMX 25.03
- EW 56.51
About FMX Fomento Economico Mexicano S.A.B. de C.V.
Mexico-based Femsa is a beverage and retail conglomerate in Central and South America. The holding company owns controlling stakes in bottler Coca-Cola Femsa (47% economic stake, 56% voting rights), in addition to operating 100%-owned retail assets, including convenience stores under the Oxxo banner, drugstores, and gas stations. The firm divested its 15% stake in Heineken and its distribution business in 2023. Coca-Cola Femsa and the Oxxo chain made up 75% of total company revenue and around 90% of profits in 2023.
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.